Firebrick Pharma Balance Sheet Health

Financial Health criteria checks 4/6

Firebrick Pharma has a total shareholder equity of A$1.6M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$1.9M and A$356.0K respectively.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ration/a
CashAU$1.31m
EquityAU$1.59m
Total liabilitiesAU$355.97k
Total assetsAU$1.95m

Recent financial health updates

Recent updates

Here's Why We're Watching Firebrick Pharma's (ASX:FRE) Cash Burn Situation

Aug 14
Here's Why We're Watching Firebrick Pharma's (ASX:FRE) Cash Burn Situation

We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

May 02
We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

Dec 14
We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

Companies Like Firebrick Pharma (ASX:FRE) Are In A Position To Invest In Growth

Aug 30
Companies Like Firebrick Pharma (ASX:FRE) Are In A Position To Invest In Growth

Financial Position Analysis

Short Term Liabilities: FRE's short term assets (A$1.8M) exceed its short term liabilities (A$356.0K).

Long Term Liabilities: FRE has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: FRE is debt free.

Reducing Debt: FRE had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: FRE has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: FRE has less than a year of cash runway if free cash flow continues to reduce at historical rates of 35.5% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.